ArticleClinical & experimental ophthalmology2025
Long-Term Morphological Changes of Crosslinked Gelatin Stent.
Article in Clinical & experimental ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Enabling adaptability and hydraulic resistance in minimally invasive glaucoma surgery using an architecture-driven approach.iScience · 2026Article
- Long-Term Morphological Changes of Crosslinked Gelatin Stent.Clinical & experimental ophthalmology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study investigates the long-term morphological outcomes of crosslinked gelatin stents over a 10-year period.
methodsParticipants from the FDA phase 1 and 2 trials for the XEN 140 stent were recalled for follow-up examinations between 9 and 12 years after their initial implantation. The stent area was evaluated using anterior segment optical coherence tomography (AS-OCT) in conjunction with clinical assessments. We focused on measuring specific alterations in stent dimensions, such as external surface pitting or 'nibbling', complete wall breaches and luminal obstruction.
resultsWe evaluated 11 eyes from 9 patients, with an average follow-up period of 11.2 years (SD ± 0.7). The mean preoperative intraocular pressure (IOP) was 22.5 mmHg (SD ± 4.9), which decreased to 14.7 mmHg (SD ± 1.2) a decade after surgery. Notably, four eyes no longer required antiglaucoma medication. Out of the 11 cases, only 8 yielded image quality suitable for analysis, all of which exhibited stent wall nibbling. The average nibbling depth was 70.17 μm (SD ± 36) in the intrascleral area, 79.5 μm (SD ± 18) in the proximal conjunctival region and 42.25 μm (SD ± 5) in the distal conjunctival region. Nibbling was most frequent in the proximal conjunctival area with 26 instances (p = 0.0006), followed by the intrascleral area, 21, and the distal conjunctival section, 9. Hyperreflective lumens were noted in five cases, with one complete stent wall discontinuity.
conclusionIn cases where imaging provided clear visibility, the stents exhibited signs of morphometric changes after 11 years. This degradation process seems to initiate externally, leading to luminal obstruction and eventual stent failure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.